An in vitro study to evaluate the synergistic activity of norfloxacin and metronidazole

Indian Journal of Pharmacology

Volumn 35, Issue 4, 2003, Pages 220-226

  Bharadwaj, R ^b   Vidya, A ^b   Dewan, B ^a   Pal, A ^c  

^a Emcure Pharmaceuticals Limited   (India)

^b B J MEDICAL COLLEGE   (India)

^c NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

Aerobes; Anaerobes; Antibiotics; MIC; Synergy

Indexed keywords

METRONIDAZOLE; NORFLOXACIN;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BLOOD CULTURE; BREAST ABSCESS; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM SPOROGENES; CONTROLLED STUDY; CULTURE MEDIUM; DIABETIC FOOT; DIARRHEA; DRUG INDICATION; DRUG POTENTIATION; ESCHERICHIA COLI; FECES CULTURE; FUSOBACTERIUM NECROPHORUM; FUSOBACTERIUM NUCLEATUM; GANGRENE; GRAM NEGATIVE INFECTION; HUMAN; IN VITRO STUDY; KLEBSIELLA; LIVER ABSCESS; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; NONHUMAN; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA MELANINOGENICA; PROTEUS; PSEUDOMONAS; PUERPERAL INFECTION; PUS; SALMONELLA; SEPSIS; SEPTICEMIA; SHIGELLA; STRAIN DIFFERENCE; TOOTH INFECTION; URINARY TRACT INFECTION; URINE CULTURE; WOUND INFECTION;

EID: 0042024879     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dollery C. Therapeutic Drugs. 2nd ed. 1999. p. N137-40, M146-50.
2. King A, Warren C, Shannon K. In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrob Agents Chemother 1982;21:604-7.
3. Ednie LM, Credito KL, Khantipong M. Synergic activity, for anaerobes, of torovafloxacin with clindamycin or metronidazole: Chequerboard and time-kill methods. J Antimicrob Chemother 2000;45:633-8.
4. Kucers A, Crowe SM, Grayson ML. The Use of Antibiotics. 5th ed. Butterworth Heinemann; Oxford: 1997. p. 936-8.
5. Neu HC. Synergy and antagonism and combinations with quinolones. Eur J Clin Microbiol Infect Dis 1991;10:255-61.
6. Collee JG, Miles RS, Watt B. Tests for Identification of Bacteria in Mackie & McCartney Practical Medical Microbiology. 14th ed. NY: Churchill Livingstone Inc.; 1996. p. 131-49.
7. Baur AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
8. Koneman EW, Allen SD, Janda WM. The anaerobic bacteria. Color Atlas and Textbook of Diagnostic Microbiology. 5th ed. Philadelphia: JP Lippincott; 1996. p. 709-75.
9. Sutter VL, Kwok YY, Finegold SM. Standard antimicrobial susceptibility testing of anaerobic bacteria. Appl Microbiol 1972;21:13-5.
10. European committee for antimicrobial susceptibility testing (Eucast), Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infec 2000;6:503-8.
11. Gail L Woods, John A Washington. Mandell, Douglas and Bennett's. The Principles and Practice of infectious Diseases. 4th ed. New York: Churchill Livingstone Inc.; 1995. p. 169-99.
12. Richard LG. Principles and syndromes of enteric infections. In: Mandell GL, Bennett JE, Dollin R, editors. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 945.
13. Romanov AE, Tsarev VN, Rudneva EV. Antibacterial therapy in the combined treatment of periodontitis. Stomatologia (Mosk) 1996;75:23-5.
14. Teng LJ, Ho SW, Chang SC, Luh KT, Hsieh WC. In vitro activities of 36 antimicrobial agents against clinically isolated Bacteroides fragilis. J Formos Med Assoc 1991;90;796-9.
15. Andaker L, Kling PA, Burman LG. Antibiotic consumption and faecal bacterial susceptibility in surgical inpatients. Acta Chir Scand 1987;153:411-6.
16. Neu HC, Chin NX. In vitro activity of fleroxacin in combination with other antimicrobial agents. Am J Med 1993;94:9-16.
17. Pavicic MJ, Van Winkelhoff AJ, De Graff J. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother 1992;36:2634-8.
18. Credito KL, Jacobs MR. Anti anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazole. Diagn Mecrobiol Infect Dis 2000;38:181-3.